These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 14131730)

  • 1. [IRON SUBTRACTION TREATMENTS IN SIDEROSIS].
    ALBAHARY C; PHU-LICH N; BOUDENE C; MARTIN S
    Therapie; 1964; 19():201-17. PubMed ID: 14131730
    [No Abstract]   [Full Text] [Related]  

  • 2. [THE TREATMENT OF HEMOCHROMATOSIS].
    TUTIN M
    Prog Med (Paris); 1964 Mar; 92():145-8. PubMed ID: 14147268
    [No Abstract]   [Full Text] [Related]  

  • 3. [CHELATION].
    RENOUX M; MIKOL C
    Presse Med (1893); 1964 Dec; 72():3117-9. PubMed ID: 14221352
    [No Abstract]   [Full Text] [Related]  

  • 4. [OUR EXPERIENCE IN THE TREATMENT OF WILSON'S DISEASE WITH PENICILLAMINE].
    BOUDIN G; PEPIN B; LAURAS A; BARRAINE R
    Rev Neurol (Paris); 1963 Jul; 109():82-6. PubMed ID: 14091678
    [No Abstract]   [Full Text] [Related]  

  • 5. [Heavy metal antidotes].
    Klimmer OR
    Arch Toxikol; 1968; 24(1):15-29. PubMed ID: 4974056
    [No Abstract]   [Full Text] [Related]  

  • 6. CHEMICAL THERAPY OF WILSON'S DISEASE.
    GOLDSTEIN NP; RANDALL RV; GROSS JB
    J Indian Med Prof; 1965 Jul; 12():5399-402. PubMed ID: 14339732
    [No Abstract]   [Full Text] [Related]  

  • 7. [MODE OF ACTION OF CHELATOR AGENTS IN THE TREATMENT OF HEPATOLENTICULAR DEGENERATION].
    OZKAN E; PRIFTI J; TAG T; AKSOY M; EKMEKCI A
    Turk Tip Cemiy Mecm; 1964 Sep; 30():612-20. PubMed ID: 14224682
    [No Abstract]   [Full Text] [Related]  

  • 8. [HEMOCHROMATOSIS].
    VERHAEGEN-DECLERCQ ML; VERHAEGEN H; DE GROOT EJ
    Belg Tijdschr Geneesk; 1964 Nov; 20():1165-74. PubMed ID: 14239616
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of Ca-EDTA, D-penicillamine and dimercaprol on toxicity of Habu snake venom.
    Kurihara Y; Kurihara N; Shibata K
    Gunma J Med Sci; 1967 Mar; 16(1):61-73. PubMed ID: 4970531
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of poisoning with heavy metals].
    Hornbostel H; Kaufmann W; Siegenthaler W
    Dtsch Med Wochenschr; 1975 Apr; 100(17):953-4. PubMed ID: 164336
    [No Abstract]   [Full Text] [Related]  

  • 11. [Recent advance in the therapy of metal poisoning with complexing agents].
    Aaseth J
    Tidsskr Nor Laegeforen; 1972 May; 12(13):918-22. PubMed ID: 4624035
    [No Abstract]   [Full Text] [Related]  

  • 12. [HEPATOCEREBRAL OR HEPATOLENTICULAR DEGENERATION].
    AKSOY M; BIYAL F; SECER F; CAKIRGOEZ C; CETINGIL AI
    Tip Fak Mecm; 1964; 27():37-55. PubMed ID: 14140395
    [No Abstract]   [Full Text] [Related]  

  • 13. INHIBITION IN VIVO OF THE ENZYMATIC INACTIVATION OF BRADYKININ AND KALLIDIN.
    ERDÖS EG; WOHLER JR
    Biochem Pharmacol; 1963 Oct; 12():1193-9. PubMed ID: 14074119
    [No Abstract]   [Full Text] [Related]  

  • 14. [TRIAL OF A NEW IRON CHELATOR, DESFERRIOXAMINE B, IN A CASE OF OCULAR SIDEROSIS].
    CHAVANNE H; DEMILLIERE B
    Bull Soc Ophtalmol Fr; 1964 Oct; 64():810-4. PubMed ID: 14306097
    [No Abstract]   [Full Text] [Related]  

  • 15. [Chemica damage to the eye in industrial medicine].
    Lange J
    Ophthalmologica; 1969; 1-3(1):95-108. PubMed ID: 5810716
    [No Abstract]   [Full Text] [Related]  

  • 16. [A DIAGNOSTIC METHOD OF OCULAR SIDEROSIS WITH ULTRAVIOLET LIGHT].
    HARUTA C
    Nihon Ganka Kiyo; 1963 Sep; 14():246-56. PubMed ID: 14062557
    [No Abstract]   [Full Text] [Related]  

  • 17. [Harmful effects of common drugs on the visual apparatus. The oligo-elements and chelating agents. B. Chelating agents].
    van Oye R
    Bull Soc Belge Ophtalmol; 1972; 160(1):255-7. PubMed ID: 4625832
    [No Abstract]   [Full Text] [Related]  

  • 18. [A NEW TEST FOR ASCERTAINMENT OF STATES OF SIDEROSIS: THE DESFERRIOXAMINE TEST. PRELIMINARY RESULTS].
    SCURO LA; BROCCIA G; DOBRILLA G; TAGLIAMONTE A
    Policlinico Prat; 1964 Jul; 71():1101-13. PubMed ID: 14174378
    [No Abstract]   [Full Text] [Related]  

  • 19. [Possible side-effects of antidotal therapy].
    Wirth W
    Arch Toxikol; 1968; 24(1):71-82. PubMed ID: 4974058
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical usefulness of iron chelating agents.
    Waxman HS; Brown EB
    Prog Hematol; 1969; 6():338-73. PubMed ID: 4976246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.